Victor Valley Times

Rep. Jay Obernolte, a U.S. Congressman representing California's 23rd District, has taken to social media to address various issues of public concern. Through a series of tweets, Obernolte has highlighted legislative initiatives and congratulated colleagues on new appointments.

On December 11, 2024, Rep. Obernolte expressed concerns over the increasing threat posed by illicit xylazine. He noted that it is often used as a cutting agent for fentanyl with serious consequences for public health. As a cosponsor of the bipartisan Combating Illicit Xylazine Act (H.R. 1839), he called for "swift congressional action to protect lives." "Illicit xylazine poses a growing threat to public health as it is often used as a cutting agent for fentanyl with devastating consequences. As a proud cosponsor of the bipartisan Combating Illicit Xylazine Act (H.R. 1839), I urge swift congressional action to protect lives and…"

Later on the same day, Obernolte congratulated Congressman Brian Babin on his appointment as the next Chairman of the Science, Space, and Technology Committee. He emphasized the committee's role in advancing scientific innovation, supporting space exploration, and promoting technological development. "Congratulations to Congressman Brian Babin on being named the next Chairman of the Science, Space, and Technology Committee. This committee advances policies that drive scientific innovation, support space exploration, and promote technological development."

On December 12, 2024, Rep. Obernolte addressed funding issues related to the United States Preventive Services Task Force (USPSTF). He pointed out that stagnant funding over more than ten years has delayed access to life-saving screenings such as new FDA-approved cancer tests. He advocated for a modest funding increase to enhance early detection capabilities and save lives. "The United States Preventive Services Task Force (USPSTF) funding has been stagnant for over 10 years, delaying access to life-saving screenings like new FDA-approved cancer tests."